Literature DB >> 11095787

Central Neurologic Complications of HIV Infection.

.   

Abstract

Human immunodeficiency virus enters the brain at the time of infection and remains in the central nervous system (CNS) throughout the infection. Three currently active topics of clinical importance will be reviewed. First, the role of cerebrospinal fluid (CSF) viral loads as a function of brain infection and performance will be assessed. Evidence is building that CSF viral load is a useful measure in assessing CNS infection in clinical trial settings with possible application to monitoring the effect of therapy in neurologically symptomatic subjects. Second, potential roles of cytokines and their receptors for CNS disease will be updated. The impact of cytokine receptors on modes of invasion of endothelial cells, monocytes, microglia, and neurons will be discussed. Finally, recently reported controlled therapeutic trials will be reviewed including the impact of antiretroviral therapy and hypothesis-driven neuroprotective strategy studies.

Entities:  

Year:  1999        PMID: 11095787     DOI: 10.1007/s11908-996-0028-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  16 in total

1.  Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.

Authors:  N A Foudraine; R M Hoetelmans; J M Lange; F de Wolf; B H van Benthem; J J Maas; I P Keet; P Portegies
Journal:  Lancet       Date:  1998-05-23       Impact factor: 79.321

2.  Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

Authors: 
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

3.  Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia.

Authors:  J T Shieh; A V Albright; M Sharron; S Gartner; J Strizki; R W Doms; F González-Scarano
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 4.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

5.  Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.

Authors:  R J Ellis; K Hsia; S A Spector; J A Nelson; R K Heaton; M R Wallace; I Abramson; J H Atkinson; I Grant; J A McCutchan
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

6.  Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.

Authors:  J C McArthur; D R McClernon; M F Cronin; T E Nance-Sproson; A J Saah; M St Clair; E R Lanier
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

7.  Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS.

Authors:  A V Vallat; U De Girolami; J He; A Mhashilkar; W Marasco; B Shi; F Gray; J Bell; C Keohane; T W Smith; D Gabuzda
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

8.  A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

Authors: 
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

9.  Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia.

Authors:  A Ghorpade; M Q Xia; B T Hyman; Y Persidsky; A Nukuna; P Bock; M Che; J Limoges; H E Gendelman; C R Mackay
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome.

Authors:  R T Johnson; J D Glass; J C McArthur; B W Chesebro
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

View more
  1 in total

Review 1.  Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin.

Authors:  M Kaul; S A Lipton
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.